Synapse - Andrew Zelenetz

Search Within

Andrew D Zelenetz

Results (785)

Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma

Journal Article

Kewalramani, T.; Nimer, S. D.; Zelenetz, A. D.; Malhotra, S.; Qin, J.; Yahalom, J.; Moskowitz, C. H.
Bone Marrow Transplantation (2003)

Fulltext@MSK | Save

Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

Journal Article

Hamlin, P. A.; Zelenetz, A. D.; Kewalramani, T.; Qin, J.; Satagopan, J. M.; Verbel, D.; Noy, A.; Portlock, C. S.; Straus, D. J.; Yahalom, J.; more...
Blood (2003)

Fulltext@MSK | Save

Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: An intent-to-treat analysis

Journal Article

Abrey, L. E.; Moskowitz, C. H.; Mason, W. P.; Crump, M.; Stewart, D.; Forsyth, P.; Paleologos, N.; Correa, D. D.; Anderson, N. D.; Caron, D.; more...
Journal of Clinical Oncology (2003)

Fulltext@MSK | Save

Inhibition of VEGFR2 mediated paracrine pathways suppresses non-Hodgkin's lymphoma xenograft growth in NOD/SCID mice

Meeting Abstract

Wang, E. S.; Zhang, K.; O'connor, O.; Zhu, Z.; Hicklin, D.; Witte, L.; Zelenetz, A.; Rafii, S.; Moore, M. A. S.
Proceedings of the American Association for Cancer Research Annual Meeting (2002)

Fulltext@MSK | Save

MUC-1 mucin protein expression correlates with advanced stage, adverse event free and overall survival in diffuse B-cell lymphoma

Meeting Abstract

Teruya-Feldstein, J.; Donnelly, G.; Goy, A.; Hegde, A.; Qin, J.; Filippa, D.; Gilles, F.; Zelenetz, A.; Houldsworth, J.; Chaganti, R. S. K.
Modern Pathology (2002)

Fulltext@MSK | Save

MUC-1 mucin protein expression correlates with advanced stage, adverse event free and overall survival in diffuse B-cell lymphoma

Meeting Abstract

Teruya-Feldstein, J.; Donnelly, G.; Goy, A.; Hegde, A.; Qin, J.; Filippa, D.; Gilles, F.; Zelenetz, A.; Houldsworth, J.; Chaganti, R. S. K.
Laboratory Investigation (2002)

Fulltext@MSK | Save

Increased chemotherapy dose attenuation in elderly patients: Evidence from surveys of practice patterns in early-stage breast cancer and non-Hodgkin's lymphoma

Meeting Abstract

Balducci, L.; Zelenetz, A. D.; Lyman, G. H.
Pharmacotherapy (2002)

Fulltext@MSK | Save

Phase II clinical experience with the proteasome inhibitor PS-341 in patients with indolent lymphomas

Meeting Abstract

O'Connor, O. A.; Moskowitz, C. H.; Wright, J. J.; Macgregor-Cortelli, B.; Straus, D.; Furst, D.; Horse-Grant, D.; Schenkein, D. P.; Zelenetz, A. D.
Blood (2002)

Fulltext@MSK | Save

Clone specific PCR detects clonal cells after radiation therapy for early stage gastric MALT lymphoma

Meeting Abstract

Noy, A.; Yahalom, J.; Zaretsky, L.; Brett, I.; Zelenetz, A. D.
Blood (2002)

Fulltext@MSK | Save

An analysis of accelerated full course chemotherapy followed by upfront high dose therapy (HDT) and autologous stem cell transplantation (ASCT) for patients with International Prognostic Index IV (IPI IV) aggressive NHL

Meeting Abstract

Moskowitz, C. H.; Kewalramani, T.; Donnelly, G.; Zelenetz, A. D.; Noy, A.; Rice, D.; Kuznetsov, M.; Straus, D.; Nimer, S. D.; Portlock, C. S.
Blood (2002)

Fulltext@MSK | Save